XPAR
VIRP
Market cap2.99bUSD
Oct 09, Last price
317.50EUR
1D
0.63%
1Q
-0.94%
Jan 2017
89.89%
Name
Virbac SA
Chart & performance
P/E
17.63
P/S
1.82
EPS
18.01
Div yield, %
0.46%
Shrs. gr., 5y
-0.11%
Rev. gr., 5y
9.41%
Revenues
1.46b
+4.82%
Net income
151m
+3.85%
CFO
196m
-4.20%
Dividend
Jul 02, 20261.45 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Related entities
Subsidiaries (13)
ALFAMED
VIRBAC (AUSTRALIA) PTY LTD
VIRBAC ANIMAL HEALTH INDIA PRIVATE LIMITED
VIRBAC CORPORATION
VIRBAC DANMARK A/S
VIRBAC DIAGNOSTICS
VIRBAC LIMITED
VIRBAC MEXICO SA DE CV
VIRBAC NEW ZEALAND LIMITED
VIRBAC NUTRITION
Virbac RSA(Pty)Ltd
VIRBAC SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
GLOBION INDIA PRIVATE LIMITED
Key people
Marie-Helene Dick-Madelpuech
Chairwoman of the Board of Directors · since 2020
Paul Martingell
Chief Executive Officer · since 2025
Pierre Madelpuech
Vice Chairman of the Board of Directors · since 2020
Habib Ramdani
Interim Chief Executive Officer, Chief Financial Officer, Member of the Executive Board · since 2024
Marc Bistuer
Deputy Chief Executive Officer, Director of Corporate Quality and Compliance, Member of the Group Executive Committee · since 2023
Francesca Cortella
Head - Corporate Human Resources, Member of the Group Executive Committee · since 2020
Sophie Favini
Head - Global Business Operations, Member of the Executive Committee · since 2023
Bertrand Havrileck
Head - Corporate Research and Development, Member of the Group Executive Committee · since 2023
Andre Mathieu
Director of Global Industrial Operations, Member of the Executive Committee · since 2023
Nathalie Pollet
Head - Global Marketing and Market Development, Member of the Group Executive Committee · since 2021
Philippe Capron
Member of the Board of Directors · since 2022
Solene Madelpuech
Member of the Board of Directors · since 2020
Luc Thielland
Member of the Board of Directors, Employee Representative · since 2024
Independent Member of the Board of Directors, Permanent Representative of OJB Conseil · since 2023
Cyrille Petit
Independent Member of the Board of Directors, Permanent Representative of Cyrille Petit Conseil · since 2020
Headquarters & legal address
1ERE AVENUE
LID 2065 M
CARROS 06510
FR
LID 2065 M
CARROS 06510
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||